BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 21
• 22
• 23
• 24
• 27
• 28
• 29

• Policy

  Roche Breast Cancer Drug Gets FDA Priority Review

  February 8, 2012

   · 

  1 min read
• Drug Development

  Merck & Co., Inc. Rotavirus Vaccine Not Linked to Bowel Problems in Study

  February 8, 2012

   · 

  1 min read
• Business

  Velomedix, Inc. Closes $10.2 Million in Series B Funds, Adds CEO and VP

  February 8, 2012

   · 

  3 min read
• BioCapital

  Merit Medical Systems, Inc. Receives FDA Warning Letter Regarding Merit Laureate(R) Hydrophilic Guidewire

  February 8, 2012

   · 

  4 min read
• Drug Development

  Forest Laboratories, Inc., Gedeon Richter Ltd.'s Cariprazine Succeeds in Third Phase III Bipolar Disorder Study

  February 8, 2012

   · 

  5 min read
• Business

  Roche Digs in for Long Fight as Illumina, Inc. Rejects $5.7 Billion Bid

  February 8, 2012

   · 

  6 min read
• BioCapital

  FDA Warning: Stomach Acid Drugs Including AstraZeneca PLC’s Nexium and Santarus Inc.'s Zegerid, Increase Risk of Bacterial Infections

  February 8, 2012

   · 

  1 min read
• Policy

  Sanofi (France), Bristol-Myers Squibb Company Receive Nearly $445 Million From Apotex Inc. Over Generic Plavix

  February 8, 2012

   · 

  4 min read
• FDA

  Sanofi (France) Announces FDA Approval of Sklice® Lotion for the Treatment of Head Lice

  February 8, 2012

   · 

  8 min read
• Business

  Sanofi (France) Profit Faces 15 Percent Hit from Cheap Drug Copies

  February 8, 2012

   · 

  1 min read